These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6367987)

  • 21. [Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components].
    Tsaras G; Ambrus J
    Rev Med Suisse Romande; 1981 Jun; 101(6):483-6. PubMed ID: 7029696
    [No Abstract]   [Full Text] [Related]  

  • 22. Safety of maprotiline in treatment of cardiac patients with left anterior hemiblock.
    Ghadirian AM; Ananth J
    Psychiatr J Univ Ott; 1989 Sep; 14(3):476-7. PubMed ID: 2678191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maprotiline (Ludiomil) in depression: a report of a monitored release study in general practice.
    Forrest WA
    J Int Med Res; 1977; 5 Suppl 4():112-5. PubMed ID: 590607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of depression in outpatients: a controlled comparison of the onset of action of amoxapine and maprotiline.
    Fabre LF
    J Clin Psychiatry; 1985 Dec; 46(12):521-4. PubMed ID: 3905772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].
    De Mendonça Lima CA; Vandel S; Bonin B; Bechtel P; Carron R
    Encephale; 1997; 23(1):48-55. PubMed ID: 9172968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological predictors of success of antidepressant drug therapy.
    Fähndrich E
    Psychiatr Dev; 1987; 5(2):151-71. PubMed ID: 3628243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
    Möller HJ; Kissling W; Herberger B; Binz U; Wendt G; Spahn H
    Pharmacopsychiatry; 1986 Sep; 19(5):362-4. PubMed ID: 3534899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting therapeutic results with levoprotiline and maprotiline in major depression: the role of the outcome criteria.
    Filip V; Höschl C; Karen P; Seifertová D; Bornová L; Prasková H; Prasko J
    Br J Psychiatry Suppl; 1993 Sep; (21):35-8. PubMed ID: 8217066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics--a study comparing adjuvant treatment with oxazolam versus chlorprothixene.
    Laux G; Koenig W; Pfaff G
    Pharmacopsychiatry; 1988 Mar; 21(2):87-92. PubMed ID: 2899329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
    Binz U; Wendt G
    Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
    [No Abstract]   [Full Text] [Related]  

  • 33. Maprotiline in pain-depression.
    Lindsay PG; Olsen RB
    J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maprotiline (Ludiomil)--another antidepressant.
    Med Lett Drugs Ther; 1981 Jun; 23(13):58-9. PubMed ID: 7017367
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of efficacy and tolerability of dothiepin hydrochloride in the management of major depression in patients suffering from rheumatoid arthritis.
    Dhavale HS; Gawande S; Bhagat V; Durge V; Londhe V; Kini S; Nadkar MY; Borges NE
    J Indian Med Assoc; 2005 May; 103(5):291-4. PubMed ID: 16229336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
    Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
    Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and electroencephalographic study of a new antidepressive agent, mono-methyl-amino-propyl-dibenzo-bicyclo-octadine hydrochloride (Ciba 34, 276 Ba)].
    Deniker P; Lôo H; Verdeaux G; Oughourlian JM
    Encephale; 1975; 1(3):265-78. PubMed ID: 1227822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.